Cargando…
Differential Expression of Claudin 1 and 4 in Basal Cell Carcinoma of the Skin
Basal cell carcinoma (BCC) is the most common human malignancy. The biological behavior of this entity is remarkably indolent. Claudin plays an important role in tight junctions, regulating paracellular passage of variable substance including growth factors and maintaining the polarity of epithelia....
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883106/ https://www.ncbi.nlm.nih.gov/pubmed/36714681 http://dx.doi.org/10.1155/2023/9936551 |
_version_ | 1784879435066900480 |
---|---|
author | Nakazawa, T. Hasegawa, A. Nagasaka, T. Yoshida, K. Guo, F. Wu, D. Hiroshima, K. Takeuchi, M. |
author_facet | Nakazawa, T. Hasegawa, A. Nagasaka, T. Yoshida, K. Guo, F. Wu, D. Hiroshima, K. Takeuchi, M. |
author_sort | Nakazawa, T. |
collection | PubMed |
description | Basal cell carcinoma (BCC) is the most common human malignancy. The biological behavior of this entity is remarkably indolent. Claudin plays an important role in tight junctions, regulating paracellular passage of variable substance including growth factors and maintaining the polarity of epithelia. Up- or downregulated claudin expression has been reported in many cancers. Nevertheless, claudin expression in BCC of the skin remains unclear. We therefore examined the status of claudin 1 and 4 expressions in BCC and adjacent normal skin by immunohistochemistry (IHC). Our IHC results demonstrated high claudin 1 expression and low claudin 4 expression in 33 of 34 lower-grade BCCs. In lower-grade BCC, claudin 1 was increased and claudin 4 was decreased compared with the normal skin. Claudin 1 was inclined to be highly expressed in the membrane and cytoplasm of tumour cells in the periphery of tumour nest. Conversely, almost all lower-grade BCCs (33/34) and one of two higher-grade BCC lacked or showed focal positivity for claudin 4. These results imply that the expression pattern is characteristics of lower-risk BCC. Interestingly, one of the two higher-grade BCCs demonstrated the converse expression patterns of claudins, with decreased claudin 1 and increased claudin 4. The combination of immunohistochemical claudin 1 and 4 expression may offer a useful ancillary tool for the pathological diagnosis of BCC. Furthermore, membranous and intracellular claudins may present future therapeutic targets for uncontrollable BCC. |
format | Online Article Text |
id | pubmed-9883106 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-98831062023-01-28 Differential Expression of Claudin 1 and 4 in Basal Cell Carcinoma of the Skin Nakazawa, T. Hasegawa, A. Nagasaka, T. Yoshida, K. Guo, F. Wu, D. Hiroshima, K. Takeuchi, M. Dermatol Res Pract Research Article Basal cell carcinoma (BCC) is the most common human malignancy. The biological behavior of this entity is remarkably indolent. Claudin plays an important role in tight junctions, regulating paracellular passage of variable substance including growth factors and maintaining the polarity of epithelia. Up- or downregulated claudin expression has been reported in many cancers. Nevertheless, claudin expression in BCC of the skin remains unclear. We therefore examined the status of claudin 1 and 4 expressions in BCC and adjacent normal skin by immunohistochemistry (IHC). Our IHC results demonstrated high claudin 1 expression and low claudin 4 expression in 33 of 34 lower-grade BCCs. In lower-grade BCC, claudin 1 was increased and claudin 4 was decreased compared with the normal skin. Claudin 1 was inclined to be highly expressed in the membrane and cytoplasm of tumour cells in the periphery of tumour nest. Conversely, almost all lower-grade BCCs (33/34) and one of two higher-grade BCC lacked or showed focal positivity for claudin 4. These results imply that the expression pattern is characteristics of lower-risk BCC. Interestingly, one of the two higher-grade BCCs demonstrated the converse expression patterns of claudins, with decreased claudin 1 and increased claudin 4. The combination of immunohistochemical claudin 1 and 4 expression may offer a useful ancillary tool for the pathological diagnosis of BCC. Furthermore, membranous and intracellular claudins may present future therapeutic targets for uncontrollable BCC. Hindawi 2023-01-20 /pmc/articles/PMC9883106/ /pubmed/36714681 http://dx.doi.org/10.1155/2023/9936551 Text en Copyright © 2023 T. Nakazawa et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Nakazawa, T. Hasegawa, A. Nagasaka, T. Yoshida, K. Guo, F. Wu, D. Hiroshima, K. Takeuchi, M. Differential Expression of Claudin 1 and 4 in Basal Cell Carcinoma of the Skin |
title | Differential Expression of Claudin 1 and 4 in Basal Cell Carcinoma of the Skin |
title_full | Differential Expression of Claudin 1 and 4 in Basal Cell Carcinoma of the Skin |
title_fullStr | Differential Expression of Claudin 1 and 4 in Basal Cell Carcinoma of the Skin |
title_full_unstemmed | Differential Expression of Claudin 1 and 4 in Basal Cell Carcinoma of the Skin |
title_short | Differential Expression of Claudin 1 and 4 in Basal Cell Carcinoma of the Skin |
title_sort | differential expression of claudin 1 and 4 in basal cell carcinoma of the skin |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883106/ https://www.ncbi.nlm.nih.gov/pubmed/36714681 http://dx.doi.org/10.1155/2023/9936551 |
work_keys_str_mv | AT nakazawat differentialexpressionofclaudin1and4inbasalcellcarcinomaoftheskin AT hasegawaa differentialexpressionofclaudin1and4inbasalcellcarcinomaoftheskin AT nagasakat differentialexpressionofclaudin1and4inbasalcellcarcinomaoftheskin AT yoshidak differentialexpressionofclaudin1and4inbasalcellcarcinomaoftheskin AT guof differentialexpressionofclaudin1and4inbasalcellcarcinomaoftheskin AT wud differentialexpressionofclaudin1and4inbasalcellcarcinomaoftheskin AT hiroshimak differentialexpressionofclaudin1and4inbasalcellcarcinomaoftheskin AT takeuchim differentialexpressionofclaudin1and4inbasalcellcarcinomaoftheskin |